Phosphoinositide 3-Kinase (PI3K) has emerged in biology as a key regulator of an ever-increasing number of cellular processes. In particular, recent interest in research is devoted to the numerous survival and apoptotic pathways controlled by PI3K and its common downstream targets in relation to cancer biology. An ever-increasing array of kinases, enzymes and transcription factors are activated in response to the simple act of PI3K 3\' phosphorylation on the inositol heads of membrane phospholipids. In *Phosphoinositide 3-Kinase signaling pathway*, Lam and co-authors attempt the daunting task of dissecting and synthesizing the current research in PI3K signaling as it relates to cell survival and apoptosis. Up-to-date research is laid out alongside reviews of important signaling pathways, so advanced undergraduates are able to understand it, yet it retains the novelty of current research in the field, particularly relating to FoxO transcription factors, so the experts in the field will find it useful.

*Phosphoinositide 3-Kinase signaling pathway* outlines the essays in a straightforward and clear manner, beginning with a review on general cell cycle signaling pathways key to PI3K signaling. Next, a thorough description of the PI3K family is given, including known homologs, their domain structures, their tissue distributions, preferred substrates, and cellular activities. The book proceeds to describe key downstream effectors of PI3K signaling, including Akt/PKB, PDK1, and FOXO transcription factors. Lam and co-authors also tend to focus on other components in phospholipid signaling such as phospholipases and phosphoinositide phosphatases. *Phosphoinositide 3-Kinase signaling pathway* describes the effects of PI3K and its targets on cell survival, apoptosis, and other cellular pathways. The authors clearly focus on PI3K\'s role in cancer-related pathways through Akt/PKD and PDK1. An interesting aspect in the section on PI3K and cancer is a treatment on cancer therapies and inhibitors designed to counteract PI3K-related cancers. Lastly, Lam gives a thorough description of PI3K\'s role in FoxO transcription factor regulation and its effect on cell cycle and organismal development control.

*Phosphoinositide 3-Kinase signaling pathway*, while informative on many topics related to PI3K, did not seem to have a cohesive front. The chapters were often full of data from many different experiments, but lacked a given focus or direction. Many authors repeated the same information in different chapters, leading to an uninteresting read in many parts of the book. Lastly, the topic is extremely broad and could have focused on smaller segments of PI3K signaling or on one effector, etc. As a common interest book, the book lacks focus and direction, but it does contain a large wealth of data and information that might be useful as a review or reference to the researcher interested in PI3K signaling or cell cycle regulation as it relates to cancer biology.
